Cargando…

Risk factors for poor outcome in patients with osmotic demyelination syndrome

Detalles Bibliográficos
Autores principales:	Peters, MA, Van der Hoeven, JG, Hoedemaekers, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363561/ http://dx.doi.org/10.1186/cc10750

Ejemplares similares

Risk factors for developing hypoglycemia in neurocritical care patients
por: Van Iersel, F, et al.
Publicado: (2009)

Interplay between the innate immune response and heart rate variability in healthy human volunteers
por: Kox, M, et al.
Publicado: (2011)

Effect of inspiration rise time on work of breathing and patient comfort during pressure support ventilation
por: Brouwer, L, et al.
Publicado: (2006)

The selective α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced inflammation and lung injury
por: Kox, M, et al.
Publicado: (2009)

Cerebral blood flow and cerebrovascular reactivity during hypothermia after cardiac arrest
por: Bisschops, L, et al.
Publicado: (2008)

Effects of viscosity on cerebral blood flow after cardiac arrest
por: Bisschops, L, et al.
Publicado: (2013)

Intensive insulin therapy does not change the inflammatory response in non-diabetic patients undergoing elective coronary artery bypass grafting
por: Hoedemaekers, C, et al.
Publicado: (2005)

Effect of the a7nAChR agonist GTS-21 on inflammation during human endotoxemia
por: Pompe, J, et al.
Publicado: (2009)

Complement activation after uncomplicated coronary artery bypass grafting: role of strict glucose control
por: Hoedemaekers, C, et al.
Publicado: (2008)

The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange
por: Kumon, Saeko, et al.
Publicado: (2017)

Extra pontine osmotic demyelination syndrome
por: Zunga, Pervaiz M, et al.
Publicado: (2015)

Osmotic demyelination syndrome in a patient with Noonan syndrome and anterior hypopituitarism
por: Chua, Tzy Harn, et al.
Publicado: (2020)

Relowering of Serum Na for Osmotic Demyelinating Syndrome
por: Yamada, Hideomi, et al.
Publicado: (2012)

Osmotic demyelination syndrome in Intensive Care Unit
por: Rao, Parnandi Bhaskar, et al.
Publicado: (2015)

Osmotic Demyelination Syndrome Triggered by Pituitary Apoplexy
por: Yokota, Yuya, et al.
Publicado: (2019)

Osmotic demyelination syndrome and thoughts on its prevention
por: Voets, Philip J. G. M., et al.
Publicado: (2021)

Osmotic Demyelination Syndrome in a Patient With Tremors
por: Ahmed, Mona, et al.
Publicado: (2022)

Measurement of cardiac output using the transpulmonary thermodilution method in the presence of high extravascular lung water in a pediatric animal model
por: Nusmeier, A, et al.
Publicado: (2011)

Occurrence of osmotic demyelination syndrome in diabetes mellitus: A case report and literature review of various etiologies for osmotic demyelination syndrome
por: Yadav, Sushil Kumar, et al.
Publicado: (2022)

Sufficient sleep quality easily measured: a multicenter centre study in dutch ICUS
por: Rood, P, et al.
Publicado: (2015)

Cortical Laminar Necrosis associated with Osmotic Demyelination Syndrome
por: Cho, A-Hyun, et al.
Publicado: (2005)

Osmotic Demyelination Syndrome Despite Appropriate Hyponatremia Correction
por: Jahan, Mansura, et al.
Publicado: (2020)

Osmotic Demyelination Syndrome in a Patient with Hypokalemia but No Hyponatremia
por: Ormonde, Carolina, et al.
Publicado: (2020)

Osmotic Demyelination Syndrome: A Rare Clinical Image
por: Koul, Prishita, et al.
Publicado: (2023)

Delayed Presentation of Osmotic Demyelination Syndrome Treated With Plasmapheresis
por: Sharif, Muhammad Waqar, et al.
Publicado: (2023)

Best prediction for need of dialysis following cardiac surgery is obtained with the Thakar model
por: Kiers, HD, et al.
Publicado: (2011)

Inflammation-induced renal injury subsides when endotoxin tolerance develops in humans as measured by urine proteomics
por: Draisma, A, et al.
Publicado: (2009)

Treating hyponatremia fast but modestly: counterbalancing risks and the fear of osmotic demyelination syndrome
por: Murt, Ahmet, et al.
Publicado: (2023)

Hypoxia and hypoxia-mimetics attenuate the inflammatory response during murine endotoxemia
por: Kiers, D, et al.
Publicado: (2015)

Albumin human/bumetanide: Osmotic demyelination syndrome: case report
Publicado: (2020)

Can osmotic demyelination syndrome be a complication of liver failure?
por: Purdy, Kaylynn, et al.
Publicado: (2020)

A Rare Case of Inadvertent Iatrogenic Osmotic Demyelination Syndrome
por: Akinbamijo, Kasopefoluwa O, et al.
Publicado: (2021)

Role of Risk Factors in Developing Osmotic Demyelination Syndrome During Correction of Hyponatremia: A Case Study
por: Reijnders, Tom D.Y., et al.
Publicado: (2020)

Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome
por: Eze, Chisom, et al.
Publicado: (2020)

Osmotic Demyelination Syndrome: Clinical, Neuroimaging Characteristics, and Outcomes in a Series of 18 Cases
por: Lv, Xinhuang, et al.
Publicado: (2021)

Factors associated with poor outcome in right heart endocarditis
por: Zamfira, Mihaela Lavinia, et al.
Publicado: (2013)

Early respiratory deterioration predicts poor outcome after aneurysmal subarachnoid hemorrhage
por: Van Lummel, E, et al.
Publicado: (2013)

Dipyridamole modulates the innate immune response during human endotoxemia
por: Ramakers, B, et al.
Publicado: (2011)

0095. Transvenous vagus nerve stimulation does not modulate the innate immune response in humans in vivo during experimental endotoxemia
por: Kox, M, et al.
Publicado: (2014)

Osmotic demyelination syndrome in a normonatremic patient of chronic kidney disease
por: Jha, Atul Abhishek, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp4l4omku3ct08s1vfs1onqvsj